Mawallafi: William Ramirez
Ranar Halitta: 15 Satumba 2021
Sabuntawa: 1 Nuwamba 2024
Anonim
Vitamin K and hemostasis
Video: Vitamin K and hemostasis

Wadatacce

Vitamin K shine bitamin da ake samu a cikin ganyayyaki koren ganye, broccoli, da Brussels sprouts. Sunan bitamin K ya fito ne daga kalmar Jamusanci "Koagulationsvitamin."

Yawancin nau'ikan bitamin K ana amfani dasu a duniya azaman magani. Vitamin K1 (phytonadione) da bitamin K2 (menaquinone) ana samunsu a Arewacin Amurka. Vitamin K1 gabaɗaya nau'in bitamin K ne wanda aka fi so saboda yana da ƙarancin guba kuma yana aiki da sauri don wasu yanayi.

Ana amfani da Vitamin K sosai don matsalolin daskarewar jini ko don juya sakamakon rage sirrin jini na warfarin.Hakanan ana amfani dashi don wasu yanayi da yawa, amma babu kyakkyawar shaidar kimiyya don tallafawa yawancin waɗannan sauran amfani.

Magunguna na Compwararren Bayanan Bayanai ƙimar tasiri bisa ga shaidar kimiyya bisa ga mizani mai zuwa: Inganci, Mai yuwuwa Mai Yiwuwa, Yiwuwar Tasiri, Yiwuwar Mara Inganci, Mai yiwuwa Mara Inganci, Mara Inganci, da suarancin Shaida don Rate.

Effectivenessimar tasiri don VITAMIN K sune kamar haka:


Inganci don ...

  • Matsalar zub da jini a jarirai jarirai masu ƙananan matakan bitamin K (cututtukan jini). Bada bitamin K1 da baki ko a matsayin harbi a cikin tsoka yana taimakawa hana matsalolin zub da jini ga jarirai. Shots ze yi aiki mafi kyau.
  • Levelsananan matakan haɓakar furotin prothrombin (hypoprothrombinemia). Shan bitamin K1 a baki ko a matsayin allura a jijiya na iya hanawa da magance matsalolin zub da jini ga mutanen da ke da ƙananan matakan prothrombin saboda amfani da wasu magunguna.
  • Rareananan cuta, cututtukan jini da aka gada (ƙarancin dalilai masu ɗauke da bitamin K ko VKCFD). Shan bitamin K ta baki ko a matsayin allura a jijiya na iya taimakawa hana zubar jini a cikin mutane masu cutar VKCFD.
  • Warwa sakamakon yaduwar jini na warfarin. Shan bitamin K1 da baki ko kuma kamar allura a jijiya na iya sauya yawan zub da jini da yake haifar da warfarin. Koyaya, allurar bitamin K1 a ƙarƙashin fata ba ze aiki ba. Shan bitamin K tare da warfarin shima kamar yana taimakawa wajen daidaita lokacin daskare jini a cikin mutanen da suke shan warfarin. Yana aiki mafi kyau ga mutanen da ke da ƙananan matakan bitamin K.

Yiwuwar tasiri ga ...

  • Kasusuwa masu rauni da rauni (osteoporosis). Samun takamaiman nau'in bitamin K2 da alama yana inganta ƙarfin ƙashi da rage haɗarin karaya a cikin yawancin tsofaffin mata masu rauni ƙasusuwa. Amma da alama ba ya amfanar mata tsofaffi waɗanda har yanzu suke da ƙasusuwa masu ƙarfi. Shan bitamin K1 da alama yana kara karfin kashi kuma yana iya hana karaya a manyan mata. Amma bazai yi aiki sosai a cikin mazan maza ba. Vitamin K1 da alama bai inganta ƙarfin ƙashi a cikin matan da ba su taɓa haila ba ko kuma cikin mutanen da ke da cutar Crohn.

Zai yuwu bashi da tasiri ga ...

  • Zub da jini cikin ko kewayen wuraren da ke cike da ruwa (ventricles) na kwakwalwa (zubar jini ta intraventricular). Bada bitamin K ga matan da ke cikin haɗari don haihuwar yara da yawa ba ze hana hana zubar jini a cikin kwakwalwar jarirai masu ciki ba. Hakanan ba ze rage haɗarin rauni na jijiya wanda waɗannan zubar jini suka haifar ba.

Evidencearancin shaida don kimanta inganci don ...

  • Wasan motsa jiki. Binciken farko ya nuna cewa shan bitamin K2 ta baki na iya inganta aikin motsa jiki ta hanyar haɓaka aikin zuciya.
  • Rashin lafiyar jini wanda ke rage matakan furotin a cikin jini da ake kira haemoglobin (beta-thalassaemia). Binciken farko ya nuna cewa shan bitamin K2 ta baki tare da alli da bitamin D na iya inganta yawan kashi a yara tare da wannan cuta ta jini.
  • Ciwon nono. Bincike ya nuna cewa yawan cin abincin bitamin K2 yana da alaƙa da ƙananan haɗarin kamuwa da cutar sankarar mama.
  • Ciwon daji. Wasu bincike sun danganta yawan cin abinci na bitamin K2, amma ba bitamin K1 ba, tare da rage haɗarin mutuwa daga cutar kansa. Amma sauran bincike sun danganta yawan cin abinci na bitamin K1, amma ba bitamin K2 ba, tare da rage haɗarin mutuwa daga cutar kansa.
  • Ciwon ido. Wasu bincike sun alakanta yawan cin abinci na bitamin K2 tare da ƙananan haɗarin kamuwa da cutar ido.
  • Ciwon hanji, kansar dubura. Binciken farko ya nuna cewa yawan cin abincin bitamin K ba shi da alaƙa da rage haɗarin cutar kansa ta cikin hanji da dubura.
  • Ciwon zuciya. Yawancin bincike sun nuna cewa yawan cin abincin bitamin K1 da K2 yana da alaƙa da rage haɗarin cututtukan zuciya. Amma yawan cin abincin bitamin K1 da alama bai rage haɗarin mutuwa daga cututtukan zuciya gaba ɗaya.
  • Cystic fibrosis. Mutanen da ke da cutar cystic fibrosis suna da ƙananan matakan bitamin K saboda matsalolin narkewar mai. Shan bitamin K yana kara matakan bitamin K. Amma babu tabbas idan yana hana matsaloli tare da daskarewar jini da ci gaban kashi a cikin waɗannan mutane.
  • Bacin rai. Binciken farko ya gano cewa yawan cin bitamin K daga abinci yana da alaƙa da ƙaramin haɗari na baƙin ciki. Amma babu wani bincike kan ko shan sinadarin bitamin K na iya rage haɗarin damuwa.
  • Ciwon suga. Binciken farko ya nuna cewa shan multivitamin mai karfi tare da bitamin K1 baya rage kasadar kamuwa da ciwon sukari idan aka kwatanta shi da shan kwayar cutar ta yau da kullun.
  • Kuraje masu kama da kuraje sanadiyyar wasu magunguna na kansar. Mutanen da aka ba su wani nau'i na maganin cutar sankarau yawanci suna kamuwa da kumburin fata. Binciken da aka fara yi ya nuna cewa sanya cream wanda ke dauke da bitamin K1 yana taimakawa hana zafin fatar cikin mutane da ake ba irin wannan magani. Amma sauran bincike sun nuna cewa amfani da maganin shafawa tare da bitamin K ba ya inganta wannan kumburin ga mutanen da suka rigaya suka ɓullo da shi.
  • Babban cholesterol. Akwai hujja ta farko cewa bitamin K2 na iya rage ƙwayar cholesterol a cikin mutane akan keɓewa tare da matakan babban ƙwayar cholesterol.
  • Ciwon hanta. Shan bitamin K2 da alama ba zai hana sake kamuwa da ciwon hanta ba. Amma wasu bincike na farko sun nuna cewa shan bitamin K2 na rage barazanar kamuwa da cutar sankarar hanta ga mutanen da ke da cutar hanta.
  • Ciwon Hanta. Yin allurar bitamin K a cikin tsoka an danganta shi da ƙananan haɗarin mutuwa ga mutanen da ke fama da ciwon hanta.
  • Ciwon huhu. Binciken farko ya nuna cewa yawan cin bitamin K2 daga abinci yana da alaƙa da raguwar haɗarin cutar sankarar huhu da mutuwar da ke da alaƙa da cutar kansa. Cin abincin bitamin K1 da alama baya da alaƙa da rage haɗarin waɗannan abubuwan.
  • Mahara sclerosis (MS). Interferon magani ne wanda ke taimakawa mutane tare da MS. Wannan magani yakan haifar da kurji da ƙonewar fata. Binciken farko ya nuna cewa yin amfani da bitamin K cream a hankali yana rage kumburi da ƙonawa a cikin mutanen da aka yiwa maganin interferon.
  • Mutuwa daga kowane dalili. Intakeananan cin bitamin K na iya haɗuwa da haɗarin haɗarin mutuwa a cikin tsofaffi masu lafiya.
  • Ciwon daji na Prostate. Binciken farko ya gano cewa yawan cin abincin bitamin K2, amma ba bitamin K1 ba, yana da alaƙa da rage haɗarin cutar sankarar prostate.
  • Rheumatoid amosanin gabbai (RA). Binciken farko ya nuna cewa shan bitamin K2 tare da maganin amosanin gabbai yana rage alamomi na kumburin haɗin gwiwa fiye da shan maganin arthritis shi kaɗai. Amma shan bitamin K1 da alama bai rage alamun RA ba.
  • Buguwa. Binciken yawan jama'a ya gano cewa cin abincin bitamin K1 ba shi da alaƙa da rage haɗarin bugun jini.
  • Isesanƙara.
  • Sonewa.
  • Scars.
  • Jijiyoyin gizo-gizo.
  • Mikewa alamomi.
  • Kumburi.
  • Sauran yanayi.
Ana buƙatar ƙarin shaida don kimanta bitamin K don waɗannan amfani.

Vitamin K muhimmin bitamin ne wanda jiki ke buƙata don ɗaukan jini, ginin ƙashi, da sauran mahimman matakai.

Lokacin shan ta bakin: Siffofin bitamin K (bitamin K1 da bitamin K2) sune KYAUTA mafi aminci ga mafi yawan mutane lokacin da aka ɗauke su yadda ya dace. Vitamin K1 10 MG kowace rana da bitamin K2 45 MG kowace rana ana amfani dasu cikin aminci har zuwa shekaru 2. Yawancin mutane ba sa fuskantar wata illa yayin shan bitamin K cikin adadin da aka ba da shawarar kowace rana. Amma wasu mutane na iya samun ciwon ciki ko gudawa.

Lokacin amfani da fata: Vitamin K1 shine MALAM LAFIYA ga mafi yawan mutane idan aka shafa su azaman cream wanda ke dauke da 0.1% bitamin K1.

Lokacin da aka ba ta ta IV: Siffofin bitamin K guda biyu (bitamin K1 da bitamin K2) sune LAFIYA LAFIYA ga mafi yawan mutane lokacin da aka yi masu allura a jijiya yadda ya kamata.

Kariya & Gargaɗi na Musamman:

Ciki da shan nono: Lokacin da aka sha cikin adadin da aka ba da shawara kowace rana, bitamin K shine LAFIYA LAFIYA ga mata masu ciki da masu shayarwa. Kada kayi amfani da adadi mai yawa ba tare da shawarar kwararrun likitocin ka ba.

Yara: Siffar bitamin K da ake kira bitamin K1 ita ce LAFIYA LAFIYA ga yara lokacin da aka kai su bakin ko allura cikin jiki yadda ya dace.

Ciwon koda: Yawan bitamin K na iya zama illa idan ana karbar maganin wankin koda saboda cutar koda.

Ciwon Hanta: Vitamin K ba shi da tasiri don magance matsalolin daskarewa sanadiyyar cutar hanta mai tsanani. A zahiri, yawan allurai na bitamin K na iya sa matsalolin ciwan jini ya zama mafi muni a cikin waɗannan mutane.

Rage ɓoyewar bile: Mutanen da ke rage yawan fitsarin bile wadanda ke shan bitamin K na iya bukatar shan gishirin bile tare da bitamin K don tabbatar da shan bitamin K.

Manjo
Kada ku ɗauki wannan haɗin.
Warfarin (Coumadin)
Jiki yana amfani da Vitamin K don taimakawa daskarewar jini. Ana amfani da Warfarin (Coumadin) don rage saurin daskarewar jini. Ta hanyar taimakon daskarewar jini, bitamin K na iya rage tasirin warfarin. Tabbatar da ana duba jininka a kai a kai. Za'a iya canza adadin warfarin ku.
Coenzyme Q10
Coenzyme Q10 yayi kama da bitamin K kuma, kamar bitamin K, na iya inganta daskarewar jini. Amfani da waɗannan samfuran guda biyu tare na iya inganta daskarewar jini fiye da amfani da guda ɗaya kawai. Wannan hadewar na iya zama matsala ga mutanen da ke shan warfarin don rage saurin daskarewar jini. Coenzyme Q10 tare da bitamin K na iya shawo kan tasirin warfarin kuma zai iya ba da damar jini ya daskare.
Tiratricol
Akwai damuwa cewa tiratricol na iya tsoma baki tare da rawar bitamin K a cikin jini.
Vitamin A
A cikin dabbobi, yawan ƙwayoyin bitamin A suna tsoma baki tare da ikon bitamin K na daskare jini. Amma ba a san ko wannan ma yana faruwa a cikin mutane ba.
Vitamin E
Babban allurai na bitamin E (misali mafi girma fiye da raka'a 800 / rana) na iya sa bitamin K ya zama ba shi da tasiri wajen daskare jini. A cikin mutanen da ke shan warfarin don kiyaye jinansu daga daskarewa, ko kuma a cikin mutanen da ke da ƙarancin bitamin K, yawancin bitamin E na iya ƙara haɗarin zubar da jini.
Fats da abinci mai dauke da mai
Cin abinci mai ɗauke da man shanu ko wasu nau'ikan abinci mai haɗari tare da abinci mai ɗauke da bitamin K, kamar alayyafo, da alama ƙara haɓakar bitamin K.
An yi nazarin ƙwayoyi masu zuwa a cikin binciken kimiyya:

MAGABATA

TA BAKI:
  • Don kasusuwa masu rauni da rauni (osteoporosis): An ɗauki nau'in MK-4 na bitamin K2 a cikin allurai na 45 MG kowace rana. Hakanan, an sha bitamin K1 a cikin allurai na 1-10 MG kowace rana.
  • Don baƙon abu, cututtukan zubar da jini da aka gada (ƙarancin dalilai masu ɗauke da bitamin K ko VKCFD): An sha 10 mg na bitamin K sau 2-3 kowane mako.
  • Don sakewa sakamakon rage sirrin jini na warfarin: Ana amfani da kwaya daya tak ta 1-5 MG na bitamin K1 don kawar da sakamakon shan warfarin da yawa. An ƙayyade ainihin adadin da ake buƙata ta gwajin gwajin da ake kira INR. Anyi amfani da allurai na kwayoyi 100-200 na bitamin K a kullun don mutanen da ke shan warfarin na dogon lokaci waɗanda ke da narkar da jini.
TARE DA BUDURWA:
  • Don baƙon abu, cututtukan zubar da jini da aka gada (ƙarancin dalilai masu ɗauke da bitamin K ko VKCFD): An yi allura na 10 na bitamin K a cikin jijiya. Sau nawa ake ba da wannan allurar ta hanyar gwajin gwaji da ake kira INR.
  • Don sakewa sakamakon rage sirrin jini na warfarin: Ana amfani da kashi ɗaya na 0.5-3 MG na bitamin K1 yawanci. An ƙayyade ainihin adadin da ake buƙata ta gwajin gwajin da ake kira INR.
YARA

DA BAKI:
  • Don matsalolin zub da jini ga jarirai jarirai masu ƙananan matakan bitamin K (cututtukan jini): 1-2 mg na bitamin K1 an bashi cikin allurai uku sama da sati 8. Hakanan an yi amfani da allurai guda ɗaya da ke ɗauke da 1 mg na bitamin K1, 5 mg na bitamin K2, ko 1-2 mg na bitamin K3.
TARE DA BUDURWA:
  • Don matsalolin zub da jini ga jarirai jarirai masu ƙananan matakan bitamin K (cututtukan jini): An ba da MG 1 na bitamin K1 a matsayin harbi a cikin jijiya.
Babu isasshen bayanan kimiyya don sanin ƙayyadadden alawus na abinci (RDAs) don bitamin K, don haka ana amfani da shawarwarin isasshen yau da kullun (AI) maimakon: AIs sune: jarirai watanni 0-6, 2 mcg; jarirai watanni 7-12, 2.5 mcg; yara 1-3 shekaru, 30 mcg; yara 4-8 shekaru, 55 mcg; yara 9-13 shekaru, 60 mcg; matasa 14-18 shekaru (gami da waɗanda ke da ciki ko masu shayarwa), 75 mcg; maza sama da shekaru 19, 120 mcg; mata sama da shekaru 19 (gami da waɗanda ke da juna biyu da masu shayarwa), 90 mcg.

2-methyl-1,4-naphthoquinone, 2-methyl-3-phytyl-1,4-naphthoquinone, 4-Amino-2-Methyl-1-Naphthol, Fat mai narkewar Vitamin, Menadiol, Menadiol Acetate, Menadiol Diacetate, Menadiol Sodium Diphosphate, Menadiol Sodium Phosphate, Menadiolum Solubile Methynaphthohydroquinone, Menadione, Ménadione, Menadione Sodium Bisulfite, Menaquinone, Ménaquinone, Menatetrenone, Menatétrenone, Phytonadione, Methylfia .

Don ƙarin koyo game da yadda aka rubuta wannan labarin, da fatan za a duba Magunguna na Compwararren Bayanan Bayanai hanya.


  1. Xiong Z, Liu Y, Chang T, et al. Hanyoyin bitamin K1 akan rayuwar marasa lafiya tare da gazawar hanta na yau da kullun: Nazarin ƙungiyar haɗin gwiwa. Magunguna (Baltimore). 2020; 99: e19619. Duba m.
  2. Turck D, Bresson JL, Burlingame B, et al. Abubuwan da aka ambata game da abinci don bitamin K. EFSA J. 2017; 15: e04780. Duba m.
  3. Shea MK, Barger K, Booth SL, et al. Matsayin Vitamin K, cututtukan zuciya, da duk abin da ke haifar da mace-mace: matakin-mai-tasiri-na kwatankwacin abokan tarayyar 3 Amurka. Am J Clin Nutr. 2020; 111: 1170-1177. Duba m.
  4. Kuang X, Liu C, Guo X, Li K, Deng Q, Li D. Haɗakar tasirin bitamin K da bitamin D akan ƙashin ƙashin ɗan adam: zane-zane na gwajin gwaji da bazuwar. Abincin Abinci. 2020; 11: 3280-3297. Duba m.
  5. Jagannath VA, Thaker V, Chang AB, Farashin AI. Arin Vitamin K don cystic fibrosis. Cochrane Database Syst Rev. 2020; 6: CD008482. Duba m.
  6. Hashimoto H, Iwasa S, Yanai-Takahashi T, et al. Bazuwar, Makafi-Makafi, Tsarin Kula da Wuri? Nazarin kan Inganci da Tsaron Vitamin K1 Maganin shafawa don Cetuximab ko Panitumumab-Cutar Acneiform Eruptions-Nazarin VIKTORIA. Gan Zuwa Kagaku Ryoho. 2020; 47: 933-939. Duba m.
  7. Mott A, Bradley T, Wright K, et al. Hanyoyin bitamin K akan ƙananan ma'adinai da ɓarna a cikin manya: sabuntawa na yau da kullun da ƙirar ƙira na gwajin gwaji. Osteoporos Int 2019; 30: 1543-59. Doi: 10.1007 / s00198-019-04949-0. Duba m.
  8. Chen HG, Sheng LT, Zhang YB, et al. Ofungiyar bitamin K tare da abubuwan da suka shafi zuciya da duk abin da ke haifar da mace-mace: nazari na yau da kullun da zane-zane. Eur J Nutr 2019; 58: 2191-205. Doi: 10.1007 / s00394-019-01998-3. Duba m.
  9. Oikonomaki T, Papasotiriou M, Ntrinias T, et al. Sakamakon bitamin K2 kari akan ƙididdigar jijiyoyin jini a cikin marasa lafiyar hemodialysis: gwajin shekara-shekara mai bin bazuwar. Int Urol Nephrol 2019; 51: 2037-44. Doi: 10.1007 / s11255-019-02275-2. Duba m.
  10. Löwensteyn YN, Jansen NJG, van Heerde M, et al. Theara yawan ƙwayar prophylaxis na baka da tasirin sa game da haɗarin zubar jini. Eur J Pediatr 2019; 178: 1033-42. Doi: 10.1007 / s00431-019-03391-y. Duba m.
  11. Shishavan NG, Gargari BP, Jafarabadi MA, Kolahi S, Haggifar S, Noroozi S. Vitaminarin Vitamin K bai canza alamomin ƙonewa da matsayin asibiti a cikin marasa lafiya da cututtukan zuciya na rheumatoid ba. Int J Vitam Nutr Sakamakon. 2018; 88 (5-6): 251-257. Duba m.
  12. Bolzetta F, Veronese N, Stubbs B, et al. Halin da ke tsakanin abincin bitamin K da cututtukan cututtuka a cikin ƙuruciya: Nazarin giciye daga babban binciken ƙungiyar. Kayan abinci. 2019; 11. pii: E787. Duba m.
  13. McFarlin BK, Henning AL, Venable AS. Amfani da baki na bitamin K2 na makwanni 8 hade da haɓakar ƙwayar zuciya mafi girma yayin motsa jiki. Sauran Lafiya na Lafiya. Shawarwari. 2017; 23: 26-32. Duba m.
  14. Camacho-Barcia ML, Bulló M, Garcia-Gavilán JF, et al. Ungiyar cin abinci na bitamin K1 mai cin abinci tare da tasirin tiyata a cikin balagaggen mazaunan Rum: bincike na biyu na gwajin asibiti da bazuwar. JAMA Ophthalmol. 2017; 135: 657-61. Duba m.
  15. Holbrook A, Schulman S, Witt DM, et al. Gudanar da shaidun tabbatar da cututtukan cututtuka: Antithrombotic Far da Rigakafin Thrombosis, 9th ed: Kwalejin Kwalejin Americanwararrun stwararrun Ewararrun Ewararrun Sharuɗɗa na Clinical Kirji 2012; 141: e152S-e184S. Duba m.
  16. Ozdemir MA, Yilmaz K, Abdulrezzak U, Muhtaroglu S, Patiroglu T, Karakukcu M, Unal E. Ingancin bitamin K2 da haɗin calcitriol akan thalassemic osteopathy. J Pediatr Hematol Oncol. 2013; 35: 623-7. Duba m.
  17. Pinta F, Ponzetti A, Spadi R, Fanchini L, Zanini M, Mecca C, Sonetto C, Ciuffreda L, Racca P. Pilot gwaji na asibiti game da ingancin amfani da kwayar cutar ta hanyar amfani da bitamin K1 cream (Vigorskin) don hana cetuximab-jawo kurji na fata a cikin marasa lafiya tare da ciwon daji na fata. Clin Colorectal Cancer. 2014; 13: 62-7. Duba m.
  18. O'Connor EM, Grealy G, McCarthy J, Desmond A, Craig O, Shanahan F, Cashman KD. Amfanin phylloquinone (bitamin K1) na tsawon watanni 12 a kan ƙididdigar matsayin bitamin K da lafiyar ƙashi a cikin marasa lafiyar manya da cutar ta Crohn. Br J Nutr. 2014; 112: 1163-74. Duba m.
  19. Lanzillo R, Moccia M, Carotenuto A, Vacchiano V, Satelliti B, Panetta V, Brescia Morra V. Vitamin K cream rage halayen a wurin allurar a cikin marasa lafiya tare da sake dawowa-sake yaduwar kwayar cutar sclerosis da yawa tare da subferaneous interferon beta - VIKING binciken. Mutuwar Scult. 2015; 21: 1215-6. Duba m.
  20. Juanola-Falgarona M, Salas-Salvadó J, Martínez-González MÁ, Corella D, Estruch R, Ros E, Fitó M, Arós F, Gómez-Gracia E, Fiol M, Lapetra J, Basora J, Lamuela-Raventós RM, Serra -Majem L, Pintó X, Muñoz MÁ, Ruiz-Gutiérrez V, Fernández-Ballart J, Bulló M. Cin abincin bitamin K yana da alaƙa da haɗarin mace-mace. J Nutr. 2014; 144: 743-50. Duba m.
  21. Huang ZB, Wan SL, Lu YJ, Ning L, Liu C, Fan SW. Shin bitamin K2 yana taka rawa a cikin rigakafi da magani na osteoporosis don mata masu auren mata: a meta-bincike na bazuwar gwajin gwaji. Osteoporos Int. 2015; 26: 1175-86. Duba m.
  22. Caluwé R, Vandecasteele S, Van Vlem B, Vermeer C, De Vriese AS. Karin Vitamin K2 a cikin marasa lafiya na hemodialysis: binciken binciken kashi-kashi. Nephrol Dial dashi. 2014; 29: 1385-90. Duba m.
  23. Abdel-Rahman MS, Alkady EA, Ahmed S. Menaquinone-7 a matsayin sabon ilimin likitancin magani don magance cututtukan zuciya na rheumatoid: Nazarin asibiti. Eur J Pharmacol. 2015; 761: 273-8. Duba m.
  24. Dennis VC, Ripley TL, Planas LG, da Beach P. Abincin bitamin K a cikin maganin marasa magani na kwayar cutar: ayyukan likitanci da ilimin ilimin saiti. J Pharm Technol 2008; 24: 69-76.
  25. Pathak A, Hamm CR, Eyal FG, Walter K, Rijhsinghani A, da Bohlman M. Maternal bitamin K gwamnati don rigakafin zubar da jini a cikin ƙananan yara. Nazarin yara 1990; 27: 219A.
  26. Kamfanin Eisai Co.Ltd. Eisai ta sanar da tsaka-tsakin bincike na binciken maganin bayan-tallan bayan sayarwa don bincika amfanin menatetrenone a matsayin wani bangare na Ma'aikatar Lafiya, Kwadago da Welfare ta Pharmacoepidemiological Drug Review Program. 2005;
  27. Shiraki M. Vitamin K2 yana haifar da haɗarin karaya da kuma kan ƙananan ƙwanƙolin ƙashin ƙashin ƙashin ƙugu a cikin osteoporosis - bazuwar buɗe ido mai saurin buɗe ido na nazarin shekaru 3. Osteoporos Int 2002; 13: S160.
  28. Greer, FR, Marshall, SP, Severson, RR, Smith, DA, Shearer, MJ, Pace, DG, and Joubert, PH Wani sabon shiri mai hade da micellar don maganin kwayar bitamin K: maganin bazuwar sarrafawa ta hanyar kirkirar kwayar cuta ta intramuscular a cikin jarirai masu ciyar da nono . Arch.Dis Yara 1998; 79: 300-305. Duba m.
  29. Wentzien, T. H., O'Reilly, R. A., da Kearns, P. J. Bincike mai yiwuwa game da juyawar kwayar cutar tare da bitamin K1 na baka yayin ci gaba da maganin warfarin bai canza ba. Kirji 1998; 114: 1546-1550. Duba m.
  30. Duong, T. M., Plowman, B. K., Morreale, A. P., da Janetzky, K. Bincike mai zuwa da kuma nazari game da maganin marasa lafiya. Magunguna na 1998; 18: 1264-1270. Duba m.
  31. Sato, Y., Honda, Y., Kuno, H., da Oizumi, K. Menatetrenone sun inganta osteopenia a cikin ɓangarorin da aka shafa na bitamin D- da marasa lafiya na bugun K. Kashi 1998; 23: 291-296. Duba m.
  32. Crowther, M. A., Donovan, D., Harrison, L., McGinnis, J., da Ginsberg, J. -arancin kwayar bitamin K mai ƙarancin ƙarfi ya sake juyayin maganin ƙwanƙwasa saboda warfarin. Thromb.Haemost. 1998; 79: 1116-1118. Duba m.
  33. Lousberg, T. R., Witt, D. M., Beall, D. G., Carter, B. L., da Malone, D. C. Bincike na maganin rigakafi da yawa a cikin ƙungiyar kula da lafiya. Arch.Intern.Med. 3-9-1998; 158: 528-534. Duba m.
  34. Fetrow, C. W., Overlock, T., da Leff, L. Antagonism na warfarin-ya haifar da hypoprothrombinemia tare da amfani da ƙananan ƙwayar bitamin K1. J.Clin. Pharmacol. 1997; 37: 751-757. Duba m.
  35. Weibert, R. T., Le, D. T., Kayser, S. R., da Rapaport, S. I. Gyara na yawan zafin jini tare da ƙananan kwayar bitamin K1. Ann.Intern.Med. 6-15-1997; 126: 959-962. Duba m.
  36. Beker, L. T., Ahrens, R. A., Fink, R.J, O'Brien, M. E., Davidson, K. W., Sokoll, L. J., da Sadowski, J. A. Tasirin karin bitamin K1 akan yanayin bitamin K a cikin marasa lafiyar cystic fibrosis. J.Pediatr.Gastroenterol.Nutr. 1997; 24: 512-517. Duba m.
  37. Bakhshi, S., Deorari, A. K., Roy, S., Paul, V.K, da Singh, M. Rigakafin rashi bitamin K wanda ya dogara da matakan PIVKA-II: na baka da hanyar intramuscular. Pediatr na Indiya. 1996; 33: 1040-1043. Duba m.
  38. Makris, M., Greaves, M., Phillips, WS, Kitchen, S., Rosendaal, FR, da Preston, EF Sauyewar maganin rigakafi na baka: ingancin dangi na infusions na sabon jini da aka daskarar da shi da kuma daskarewa kan mai da hankali kan gyaran coagulopathy . Thromb.Haemost. 1997; 77: 477-480. Duba m.
  39. Ulusahin, N., Arsan, S., da Ertogan, F. Hanyoyin maganin kwayar bitamin K na kwayar cuta da na intramuscular a kan sigogin gwaji na PIVKA-II a cikin jarirai masu shayarwa a Turkiyya. Turk.J.Pediatr. 1996; 38: 295-300. Duba m.
  40. Gijsbers, B. L., Jie, K. S., da Vermeer, C. Sakamakon tasirin abinci akan bitamin K sha a cikin masu sa kai na mutane. Br.J.Nutr. 1996; 76: 223-229. Duba m.
  41. Thijssen, H. H. da Drittij-Reijnders, M. J. Matsayi na Vitamin K a cikin jikin ɗan adam: takamaiman ƙwayar nama na phylloquinone da menaquinone-4. Br.J.Nutr. 1996; 75: 121-127. Duba m.
  42. White, R.H, McKittrick, T., Takakuwa, J., Callahan, C., McDonell, M., da Fihn, S. Gudanarwa da hangen nesa na zubar da jini mai barazanar rai yayin maganin warfarin. Consungiyar Consortium ta icoasa ta Cibiyoyin Anticoagulation. Arch.Intern.Med. 6-10-1996; 156: 1197-1201. Duba m.
  43. Sharma, R.K, Marwaha, N., Kumar, P., da Narang, A. Sakamakon bitamin K mai narkewar ruwa mai narkewa akan matakan PIVKA-II a jarirai. Pediatr na Indiya. 1995; 32: 863-867. Duba m.
  44. Brousson, M. A. da Klein, M. C. Tattaunawa game da gudanar da bitamin K ga jarirai: nazari. CMAJ. 2-1-1996; 154: 307-315. Duba m.
  45. Cornelissen, E. A., Kollee, L. A., van Lith, T. G., Motohara, K., da Monnens, L. A. Bincike na adadin yau da kullun na microgram 25 micro1 don hana rashi bitamin K a jarirai masu shayarwa. J.Pediatr.Gastroenterol.Nutr. 1993; 16: 301-305. Duba m.
  46. Hogenbirk, K., Peters, M., Bouman, P., Sturk, A., da Buller, HA Sakamakon dabara ta hanyar ciyar da nono da karin kimiyyar bitamin K1 akan matakan yaduwar bitamin K1 da abubuwan ciwan bitamin K masu dogaro jarirai. Eur.J.Pediatr. 1993; 152: 72-74. Duba m.
  47. Cornelissen, E. A., Kollee, L. A., De Abreu, R. A., Motohara, K., da Monnens, L. A. Rigakafin rashin ƙarancin bitamin K a ƙuruciya ta hanyar gudanarwar mako-mako na bitamin K. Acta Paediatr. 1993; 82: 656-659. Duba m.
  48. Klebanoff, M. A., Karanta, J. S., Mills, J. L., da Shiono, P. H. Rashin haɗarin cutar ƙarancin yara bayan bayyanar jariri ga bitamin K. N.Engl.J.Med. 9-23-1993; 329: 905-908. Duba m.
  49. Dickson, R.C, Stubbs, T. M., da Lazarchick, J. Antenatal bitamin K far na ƙananan yara masu nauyin haihuwa. Am.J.ObstetGynecol. 1994; 170 (1 Pt 1): 85-89. Duba m.
  50. Pengo, V., Banzato, A., Garelli, E., Zasso, A., da Biasiolo, A. Rushewar sakamako mai yawa na maganin rigakafi na yau da kullun: ƙananan ƙwayar ƙwayar phytonadione (bitamin K1) idan aka kwatanta da katsewar warfarin. Jigilar jini. Fibrinolysis 1993; 4: 739-741. Duba m.
  51. Thorp, JA, Parriott, J., Ferrette-Smith, D., Meyer, BA, Cohen, GR, da Johnson, J. Antepartum bitamin K da phenobarbital don hana zubar jini ta cikin jini a cikin jariri wanda bai kai ga haihuwa ba: bazuwar, makafi biyu, gwajin sarrafa wuribo. Obstet.Gynecol. 1994; 83: 70-76. Duba m.
  52. Maurage, C., Dalloul, C., Moussa, F., Cara, B., Dudragne, D., Lion, N., da Amedee-Manesme, O. [Ingantaccen aikin baka na maganin micellaar na bitamin K yayin lokacin haihuwa]. Arch.Pediatr. 1995; 2: 328-332. Duba m.
  53. Taberner, D. A., Thomson, J. M., da Poller, L. Kwatanta haɗin ƙwayoyin prothrombin da bitamin K1 a cikin juyawar maganin ƙetare. Tsakar Gida 7-10-1976; 2: 83-85. Duba m.
  54. Glover, J. J. da Morrill, G. B. Maganin masu ra'ayin mazan jiya na marasa lafiyar da suka fi karfinsu. Kirji 1995; 108: 987-990. Duba m.
  55. Jie, K. S., Bots, M. L., Vermeer, C., Witteman, J. C., da Grobbee, D. E. Vitamin K cin abinci da matakan osteocalcin a cikin mata tare da ba tare da atherosclerosis ba: nazarin yawan jama'a. Maganin Atherosclerosis 1995; 116: 117-123. Duba m.
  56. Sutherland, J. M., Glueck, H. I., da Gleser, G. Ciwon hawan jini na jariri. Ciyar da nono a matsayin muhimmin abu a cikin kwayar cutar. Am J.Dis Yara 1967; 113: 524-533. Duba m.
  57. Motohara, K., Endo, F., da Matsuda, I. Rikicin Vitamin K a cikin jariran da ke shayar da nono a wata ɗaya da haihuwa. J.Pediatr.Gastroenterol.Nutr. 1986; 5: 931-933. Duba m.
  58. Pomerance, J. J., Teal, J. G., Gogolok, J. F., Brown, S., da Stewart, M. E. Ana gudanar da bitamin K1 na haihuwa ta hanyar haihuwa: sakamako a kan aikin prothrombin na jarirai, lokacin thromboplastin na wani lokaci, da kuma zubar jini ta intraventricular. Obstet.Gynecol. 1987; 70: 235-241. Duba m.
  59. O’Connor, M. E. da Addiego, J. E., Jr. Amfani da bitamin K1 na baka don hana cutar zubar jini na jariri sabon haihuwa. J.Pediatr. 1986; 108: 616-619. Duba m.
  60. Morales, W. J., Angel, J. L., O'Brien, W. F., Knuppel, R. A., da Marsalisi, F. Yin amfani da bitamin K a cikin rigakafin farkon zubar jini na cikin jini. Am.J.ObstetGynecol. 1988; 159: 774-779. Duba m.
  61. Motohara, K., Endo, F., da Matsuda, I. Tasirin gudanarwar bitamin K akan matakan acarboxy prothrombin (PIVKA-II) a cikin jarirai. Lancet 8-3-1985; 2: 242-244. Duba m.
  62. Propranolol yana hana zuban jini na farko na hanji a cikin marasa lafiyar cirrhotic. Rahoton ƙarshe na gwajin bazuwar ƙasa da yawa. Masar Multicenter ta Italiyanci don Propranolol a Rigakafin Zuban jini. J.Hepatol. 1989; 9: 75-83. Duba m.
  63. Kazzi, N. J., Ilagan, N. B., Liang, KC, Kazzi, G. M., Poland, R.L, Grietsell, L. A., Fujii, Y., da Brans, Y. W Maternal na kula da bitamin K baya inganta haɓakar haɓakar ƙwayar jarirai. Ilimin yara na yara 1989; 84: 1045-1050. Duba m.
  64. Yang, Y. M., Simon, N., Maertens, P., Brigham, S., da Liu, P. Maternal-fetal jigilar bitamin K1 da illolin da take yi a kan tarawar jarirai da wuri. J.Pediatr. 1989; 115: 1009-1013. Duba m.
  65. Martin-Lopez, JE, Carlos-Gil, AM, Rodriguez-Lopez, R., Villegas-Portero, R., Luque-Romero, L., da Flores-Moreno, S. [Prophylactic bitamin K na zub da jini na bitamin K jariri.]. Gona.Hosp. 2011; 35: 148-55. Duba m.
  66. Chow, C. K. Abincin abincin menaquinones da haɗarin kamuwa da cutar kansa da mace-mace. AmJJlinNutr. 2010; 92: 1533-1534. Duba m.
  67. Rees, K., Guraewal, S., Wong, YL, Majanbu, DL, Mavrodaris, A., Stranges, S., Kandala, NB, Clarke, A., da Franco, OH Shin amfani da bitamin K ne wanda ke da alaƙa da cardio-metabolic cuta? Binciken na yau da kullun. Maturitas 2010; 67: 121-128. Duba m.
  68. Napolitano, M., Mariani, G., da Lapecorella, M. Rashin haɗin gado ya haɗu da ƙananan ƙwayoyin bitamin K masu dogara. Marayu. J. Rare.Dis. 2010; 5:21. Duba m.
  69. Dougherty, K. A., Schall, J. I., da Stallings, V. A. Suboptimal bitamin K matsayi duk da ƙarin yara da samari tare da cystic fibrosis. AmJJlinNutr. 2010; 92: 660-667. Duba m.
  70. Novotny, J. A., Kurilich, A. C., Britz, S.J, Baer, ​​D. J., da Clevidence, B. A. Vitamin K sha da sinadarin motsa jiki a cikin batutuwa na mutum bayan amfani da phylloquinone mai lamba 13C daga kale. Br.J.Nutr. 2010; 104: 858-862. Duba m.
  71. Jorgensen, F. S., Felding, P., Vinther, S., da Andersen, G. E. Vitamin K ga yara masu zuwa. Peroral da tsarin intramuscular. Dokar Paediatr.Sand. 1991; 80: 304-307. Duba m.
  72. Nimptsch, K., Rohrmann, S., Kaaks, R., da Linseisen, J. Abincin bitamin K cin abinci dangane da cutar kansa da mace-mace: sakamako daga ƙungiyar Heidelberg na Europeanungiyar Binciken Turai game da Ciwon Kanjamau da Gina Jiki (EPIC-Heidelberg ). AmJJlinNutr. 2010; 91: 1348-1358. Duba m.
  73. Yamauchi, M., Yamaguchi, T., Nawata, K., Takaoka, S., da Sugimoto, T. Dangantaka tsakanin osteocalcin undercarboxylated da cin abinci na bitamin K, juyawar kashi, da ƙimar ma'adinan ƙashi a cikin mata masu lafiya. Clin.Nutr. 2010; 29: 761-765. Duba m.
  74. Shea, MK, Booth, SL, Gundberg, CM, Peterson, JW, Waddell, C., Dawson-Hughes, B., da Saltzman, E. Yawan kiba na girma yana da alaƙa da haɗuwa da ƙwayoyin ƙwayoyin ƙwayoyin bitamin K kuma suna da alaƙa da kewaya masu nuna alamar bitamin K a cikin maza da mata. J.Nutr. 2010; 140: 1029-1034. Duba m.
  75. Crowther, C. A., Crosby, D. D., da Henderson-Smart, D. J. Vitamin K kafin haihuwa kafin lokacin haihuwa don hana zubar jini na cikin mahaifa. Cochrane.Database.Syst.Rev. 2010;: CD000229. Duba m.
  76. Iwamoto, J. [Rashin ingancin karaya na bitamin K]. Clin Calcium 2009; 19: 1805-1814. Duba m.
  77. Stevenson, M., Lloyd-Jones, M., da Papaioannou, D. Vitamin K don hana ɓarna a cikin tsofaffin mata: nazari na yau da kullun da kimanta tattalin arziki. Kiwon Lafiya Technol. 2009; 13: iii-134. Duba m.
  78. Yoshiji, H., Noguchi, R., Toyohara, M., Ikenaka, Y., Kitade, M., Kaji, K., Yamazaki, M., Yamao, J., Mitoro, A., Sawai, M., Yoshida, M., Fujimoto, M., Tsujimoto, T., Kawaratani, H., Uemura, M., da Fukui, H. Haɗuwa da bitamin K2 da mai hana enzyme mai canza angiotensin suna ameliorates sake dawo da cutar sankarar hanta. J.Hepatol. 2009; 51: 315-321. Duba m.
  79. Iwamoto, J., Matsumoto, H., da Takeda, T. Inganci na menatetrenone (bitamin K2) a kan rashin laka da kashin baya a cikin marasa lafiya tare da cututtukan jijiyoyin jiki: meta-bincike na uku bazuwar, gwajin sarrafawa. Clin.Drug Investig. 2009; 29: 471-479. Duba m.
  80. Crosier, MD, Peter, I., Booth, SL, Bennett, G., Dawson-Hughes, B., da Ordovas, JM Associationungiyar ƙungiya ta bambance-bambancen cikin bitamin K epoxide reductase da gamma-glutamyl carboxylase genes tare da matakan biochemical na bitamin K matsayi. J.Nutr.Sci.Vitaminol. (Tokyo) 2009; 55: 112-119. Duba m.
  81. Iwamoto, J., Sato, Y., Takeda, T., da Matsumoto, H. -ara yawan bitamin K yana rage haɗarin ɓarna a cikin matan da suka gama aure: nazarin littattafai. Nutr.Res. 2009; 29: 221-228. Duba m.
  82. Shea, MK, O'Donnell, CJ, Hoffmann, U., Dallal, GE, Dawson-Hughes, B., Ordovas, JM, Farashin, PA, Williamson, MK, da Booth, SL Vitamin K kari da ci gaban jijiyoyin jijiyoyin jini alli a cikin tsofaffi maza da mata. AmJJlinNutr. 2009; 89: 1799-1807. Duba m.
  83. Takaitawa ga marasa lafiya. Shin bitamin K yana taimakawa ga mutanen da suka sha warfarin da yawa? Ann.Intern.Med. 3-3-2009; 150: I25. Duba m.
  84. Kim, HS, Park, JW, Jang, JS, Kim, HJ, Shin, WG, Kim, KH, Lee, JH, Kim, HY, da Jang, MK Tsarin kimantawa na alpha-fetoprotein da furotin da aka samu ta rashin bitamin K ko antagonist-II a cikin cututtukan hepatocellular da ke da alaƙa da cutar hepatitis B: nazari mai yiwuwa. J.Clin.Gastroenterol. 2009; 43: 482-488. Duba m.
  85. Inoue, T., Fujita, T., Kishimoto, H., Makino, T., Nakamura, T., Nakamura, T., Sato, T., da Yamazaki, K. Nazarin binciken da bazuzu akan rigakafin cututtukan osteoporotic ( OF binciken): wani lokaci na IV binciken asibiti na 15-mg menatetrenone capsules. J.Bone Miner.Metab 2009; 27: 66-75. Duba m.
  86. Cheung, AM, Tile, L., Lee, Y., Tomlinson, G., Hawker, G., Scher, J., Hu, H., Vieth, R., Thompson, L., Jamal, S., da kuma Josse, R. Vitaminarin Vitamin K a cikin matan postmenopausal da osteopenia (gwajin ECKO): gwajin bazuwar sarrafawa. Rariya. 10-14-2008; 5: e196. Duba m.
  87. Ishida, Y. [Vitamin K2]. Clin Calcium 2008; 18: 1476-1482. Duba m.
  88. Hathaway, WE, Isarangkura, PB, Mahasandana, C., Jacobson, L., Pintadit, P., Pung-Amritt, P., da Green, GM Kwatanta maganin kwayar bitamin K na baka da na iyaye don rigakafin ƙarshen cutar rashin jini na cutar sabuwar haihuwa. J.Pediatr. 1991; 119: 461-464. Duba m.
  89. Iwamoto, J., Takeda, T., da Sato, Y. Matsayin bitamin K2 a cikin maganin cututtukan postmenopausal osteoporosis. Curr.Drug Saf 2006; 1: 87-97. Duba m.
  90. Marti-Carvajal, A. J., Cortes-Jofre, M., da Marti-Pena, A. J. Vitamin K don zub da jini na hanji na sama a cikin marasa lafiya da cututtukan hanta. Cochrane.Database.Syst.Rev. 2008;: CD004792. Duba m.
  91. Drury, D., Gray, V. L., Ferland, G., Gundberg, C., da Lands, L. C. Inganci na babban kwayar phylloquinone wajen gyara rashi bitamin K a cikin cystic fibrosis. J.Cyst.Fibros. 2008; 7: 457-459. Duba m.
  92. Macdonald, HM, McGuigan, FE, Lanham-New, SA, Fraser, WD, Ralston, SH, da Reid, DM Abincin Vitamin K1 yana haɗuwa da haɓakar ma'adinai mafi girma kuma rage haɓakar ƙashi a farkon matan Scottish bayan sun gama aure: babu shaidar kwayar halitta -tataccen hulɗa tare da apolipoprotein E polymorphisms. AmJJlinNutr. 2008; 87: 1513-1520. Duba m.
  93. Nimptsch, K., Rohrmann, S., da Linseisen, J. Cin abinci mai gina jiki na bitamin K da kuma barazanar kamuwa da cutar kansar mafitsara a cikin ƙungiyar Heidelberg ta Europeanungiyar Binciken Turai game da Ciwon Cutar Kanjamau da Abinci (EPIC-Heidelberg). AmJJlinNutr. 2008; 87: 985-992. Duba m.
  94. Hotta, N., Ayada, M., Sato, K., Ishikawa, T., Okumura, A., Matsumoto, E., Ohashi, T., da Kakumu, S. Sakamakon bitamin K2 kan sake dawowa cikin marasa lafiya carcinoma hepatocellular. Hepatogastroenterology 2007; 54: 2073-2077. Duba m.
  95. Urquhart, D. S., Fitzpatrick, M., Cope, J., da Jaffe, A. Vitamin K wanda ke ba da umarni da kula da lafiyar ƙashi a cikin yaran Burtaniya tare da cystic fibrosis. J.Hum.Nutr.Diet. 2007; 20: 605-610. Duba m.
  96. Hosoi, T. [Jiyya na osteoporosis na farko tare da bitamin K2]. Clin Calcium 2007; 17: 1727-1730. Duba m.
  97. Jones, K. S., Bluck, L. J., Wang, L. Y., da Coward, W. A. ​​Hanyar isotope mai karko don daidaitaccen ma'aunin bitamin K1 (phylloquinone) kinetics da sha. Eur.J.Clin.Nutr. 2008; 62: 1273-1281. Duba m.
  98. Knapen, M. H., Schurgers, L. J., da Vermeer, C. Vitaminarin Vitamin K2 yana inganta haɓakar ƙashin ƙugu da ƙashin ƙashi a cikin matan postmenopausal. Osteoporos.Int. 2007; 18: 963-972. Duba m.
  99. Maas, A. H., van der Schouw, Y. T., Beijerinck, D., Deurenberg, J. J., Mali, W. P., Grobbee, D. E., da van der Graaf, Y. Vitamin K ci da ƙididdiga a cikin jijiyoyin mama. Maturitas 3-20-2007; 56: 273-279. Duba m.
  100. Dentali, F., Ageno, W., da Crowther, M. Jiyya na coumarin da ke hade da coagulopathy: nazari na yau da kullun da kuma hanyoyin samar da hanyoyin samar da magani. J.Thromb.Haemost. 2006; 4: 1853-1863. Duba m.
  101. Liu, J., Wang, Q., Zhao, J. H., Chen, Y. H., da Qin, G. L JTrop.Pediatr. 2006; 52: 355-359. Duba m.
  102. Liu, J., Wang, Q., Gao, F., He, JW, da Zhao, JH na kula da lafiyar mahaifiya na bitamin K1 yana haifar da haɓaka ayyukan abubuwan haɗin keɓaɓɓen bitamin K a cikin jinin mahaifa da kuma rage yawan abin da ke faruwa. na cututtukan jini na ciki wanda bai dace ba a cikin jarirai wanda bai kai ba. J.Perinat.Med. 2006; 34: 173-176. Duba m.
  103. Dezee, K. J., Shimeall, W. T., Douglas, K. M., Shumway, N. M., da O'malley, P. G. Jiyya na maganin rigakafi da yawa tare da phytonadione (bitamin K): meta-analysis. Arch.Intern.Med. 2-27-2006; 166: 391-397. Duba m.
  104. Thijssen, H. H., Vervoort, L. M., Schurgers, L. J., da Shearer, M.J.Menadione shine maganin ƙwayar bitamin K. Br.J.Nutr. 2006; 95: 260-266. Duba m.
  105. Goldstein, JN, Thomas, SH, Frontiero, V., Joseph, A., Engel, C., Snider, R., Smith, EE, Greenberg, SM, da Rosand, J. Timing na sabon ruwan plasma mai sanyi da saurin gyarawa na coagulopathy a cikin warfarin da ke da nasaba da zubar jini a cikin jini.Bugun 2006; 37: 151-155. Duba m.
  106. Shetty, H. G., Backhouse, G., Bentley, D. P., da Routledge, P. A. Ingantaccen tasiri na warfarin ya haifar da yawan maganin hana yaduwar kwayar cutar tare da karancin bitamin K1. Thromb.Haemost. 1-23-1992; 67: 13-15. Duba m.
  107. Ageno, W., Garcia, D., Silingardi, M., Galli, M., da Crowther, M. Wani gwajin da aka yi na bazuwar kwatanta 1 MG na bitamin K ba tare da magani ba a cikin kula da coagulopathy mai haɗin warfarin a cikin marasa lafiya tare da inji bawul na zuciya. J.Coll.Cardiol. 8-16-2005; 46: 732-733. Duba m.
  108. Villines, T. C., Hatzigeorgiou, C., Feuerstein, I. M., O'malley, P. G., da Taylor, A. J. Vitamin K1 cin abinci da ƙididdigar jijiyoyin jini. Ciwan jijiya. 2005; 16: 199-203. Duba m.
  109. Yasaka, M., Sakata, T., Naritomi, H., da Minematsu, K. Matsayi mafi kyau na kwayar prothrombin don mayar da hanzari ga juyawar maganin ƙwayar baki. YankinRes. 2005; 115: 455-459. Duba m.
  110. Sato, Y., Honda, Y., Hayashida, N., Iwamoto, J., Kanoko, T., da Satoh, K. Vitamin K rashi da osteopenia a cikin mata tsofaffi masu cutar Alzheimer. Arch.Phys.Med.Rehabil. 2005; 86: 576-581. Duba m.
  111. Sato, Y., Kanoko, T., Satoh, K., da Iwamoto, J. Menatetrenone da bitamin D2 tare da sinadarin calcium sun hana raunin da ya faru ga tsofaffi mata da ke fama da cutar Alzheimer. Kashi 2005; 36: 61-68. Duba m.
  112. Sasaki, N., Kusano, E., Takahashi, H., Ando, ​​Y., Yano, K., Tsuda, E., da Asano, Y. Vitamin K2 yana hana ɓarkewar kashi na glucocorticoid wani ɓangare ta hana rage osteoprotegerin (OPG). J.Bone Miner. Metab 2005; 23: 41-47. Duba m.
  113. Kalkwarf, H. J., Khoury, J. C., Bean, J., da Elliot, J. G. Vitamin K, jujjuyawar kashi, da yawan kasusuwa a cikin yan mata. AmJJlinNutr. 2004; 80: 1075-1080. Duba m.
  114. Habu, D., Shiomi, S., Tamori, A., Takeda, T., Tanaka, T., Kubo, S., da Nishiguchi, S. Matsayi na bitamin K2 a cikin ci gaban cututtukan hanta na hanta a cikin mata masu fama da cutar cirrhosis na hanta. JAMA 7-21-2004; 292: 358-361. Duba m.
  115. Dentali, F. da Ageno, W. Gudanar da coaguarin haɗuwa da coagulopathy a cikin mai haƙuri mara jini: nazari na yau da kullun. Haematologica 2004; 89: 857-862. Duba m.
  116. Lubetsky, A., Hoffman, R., Zimlichman, R., Eldor, A., Zvi, J., Kostenko, V., da Brenner, B. Inganci da amincin hadadden kwayar prothrombin (Octaplex) don saurin juyawa maganin hana daukar ciki na baki. YankinRes. 2004; 113: 371-378. Duba m.
  117. Braam, L. A., Knapen, M. H., Geusens, P., Brouns, F., da Vermeer, C. Abubuwan da ke shafar lalacewar kashi a cikin 'yan wasa mata masu juriya: nazari na biye da shekaru biyu. Am.J Sports Med. 2003; 31: 889-895. Duba m.
  118. Lubetsky, A., Yonath, H., Olchovsky, D., Loebstein, R., Halkin, H., and Ezra, D. Kwatantawa da maganin cikin jiki da kuma maganin cikin jiki (bitamin K1) a cikin marasa lafiya tare da yawan zafin jini: mai yiwuwa bazuwar sarrafawa karatu. Arch.Intern.Med. 11-10-2003; 163: 2469-2473. Duba m.
  119. Braam, L. A., Knapen, M. H., Geusens, P., Brouns, F., Hamulyak, K., Gerichhausen, M. J., da Vermeer, C. Vitamin K1 kari yana haifar da asarar kashi a cikin mata masu haihuwa bayan shekaru 50 zuwa 60. Calcif.Tausa Int. 2003; 73: 21-26. Duba m.
  120. Cornelissen, EA, Kollee, LA, De Abreu, RA, van Baal, JM, Motohara, K., Verbruggen, B., da Monnens, LA Hanyoyin maganin kwayar bitamin K na baka da intramuscular akan bitamin K1, PIVKA-II, da kuma dalilai a cikin jarirai masu ciyar da nono. Arch.Dis Yara 1992; 67: 1250-1254. Duba m.
  121. Malik, S., Udani, R.H, Bichile, S. K., Agrawal, R. M., Bahrainwala, A. T., da Tilaye, S. Nazarin kwatancen maganganu game da maganin bitamin K a cikin yara. Pediatr na Indiya. 1992; 29: 857-859. Duba m.
  122. VIETTI, T. J., MURPHY, T. P., JAMES, J. A., da PRITCHARD, J. A. Lura kan amfani da kwayar cutar bitamin Kin jariri. J.Pediatr. 1960; 56: 343-346. Duba m.
  123. Tabb, MM, Rana, A., Zhou, C., Grun, F., Errandi, J., Romero, K., Pham, H., Inoue, S., Mallick, S., Lin, M., Forman , BM, da Blumberg, B. Dokokin Vitamin K2 na homeostasis na tsakiya sunyi sulhu ne ta hanyar steroid da mai karɓar xenobiotic SXR. J Biol.Chem. 11-7-2003; 278: 43919-43927. Duba m.
  124. Sorensen, B., Johansen, P., Nielsen, G. L., Sorensen, J. C., da Ingerslev, J. Reversal na International Normalized Ratio tare da recombinant mai kunnawa factor VII a cikin tsakiyar juyayi tsarin jini yayin warfarin thromboprophylaxis: asibiti da biochemical al'amurran. Jigilar jini. Fibrinolysis 2003; 14: 469-477. Duba m.
  125. Poli, D., Antonucci, E., Lombardi, A., Gensini, GF, Abbate, R., da Prisco, D. Tsaro da tasirin ingancin kwayar cutar ta K1 a cikin marasa lafiya marasa lafiya a warfarin ko acenocoumarol tare da wuce kima maganin hana yaduwar jini. Haematologica 2003; 88: 237-238. Duba m.
  126. Yasaka, M., Sakata, T., Minematsu, K., da Naritomi, H. Gyara INR ta haɗakar kwayar prothrombin da bitamin K a cikin marasa lafiya da ke fama da warfarin da ke da nasaba da zubar jini. YankinRes. 10-1-2002; 108: 25-30. Duba m.
  127. Booth, SL, Broe, KE, Gagnon, DR, Tucker, KL, Hannan, MT, McLean, RR, Dawson-Hughes, B., Wilson, PW, Cupples, LA, da Kiel, DP Vitamin K cin abinci da ƙimar ma'adinan ƙashi a cikin mata da maza. AmJJlinNutr. 2003; 77: 512-516. Duba m.
  128. Deveras, R. A. da Kessler, C. M. Rushewar warfarin-ya haifar da matsanancin maganin hana yaduwar cutar tare da mahimmin abu na mutum VIIa mai da hankali. Ann.Intern.Med. 12-3-2002; 137: 884-888. Duba m.
  129. Riegert-Johnson, D. L. da Volcheck, G. W. Halin anaphylaxis yana biye da ƙwayar phytonadione (bitamin K1): nazari na shekaru 5. Ann.Allergy Asthma Immunol. 2002; 89: 400-406. Duba m.
  130. Crowther, MA, Douketis, JD, Schnurr, T., Steidl, L., Mera, V., Ultori, C., Venco, A., da Ageno, W. Oral bitamin K yana rage daidaitattun ƙasashe cikin sauri fiye da subcutaneous bitamin K a cikin maganin warfarin da ke hade da coagulopathy. Gwajin da bazuwar, gwajin sarrafawa Ann.Intern.Med. 8-20-2002; 137: 251-254. Duba m.
  131. Ageno, W., Crowther, M., Steidl, L., Ultori, C., Mera, V., Dentali, F., Squizzato, A., Marchesi, C., da Venco, A. Lowananan maganin bitamin K don magance acenocoumarol-wanda ya haifar da coagulopathy: gwajin gwajin da bazuwar. Thromb.Haemost. 2002; 88: 48-51. Duba m.
  132. Sato, Y., Honda, Y., Kaji, M., Asoh, T., Hosokawa, K., Kondo, I., da Satoh, K. Amelioration na osteoporosis da menatetrenone a cikin tsofaffi mata masu cutar Parkinson tare da rashin bitamin D . Kashi 2002; 31: 114-118. Duba m.
  133. Olson, R. E., Chao, J., Graham, D., Bates, M. W., da Lewis, J. H. Jimlar jiki phylloquinone da juyawar sa a cikin batutuwa na mutane a matakai biyu na cin bitamin K. Br.J.Nutr. 2002; 87: 543-553. Duba m.
  134. Andersen, P. da Godal, H. C. Rage tsinkaya a cikin ayyukan maganin warfarin ta ƙananan bitamin K. Acta Med.Scand. 1975; 198: 269-270. Duba m.
  135. Preston, F. E., Laidlaw, S. T., Sampson, B., da Kitchen, S. Saurin juyawar maganin hana daukar ciki tare da warfarin ta hanyar kwayar prothrombin (Beriplex): inganci da aminci a cikin marasa lafiya 42. Br.J Haematol. 2002; 116: 619-624. Duba m.
  136. Evans, G., Luddington, R., da Baglin, T. Beriplex P / N sun sake jujjuyawar warfarin da ke haifar da overanticoagulation nan take kuma gaba daya ga marasa lafiyar da ke fama da babban zubar jini. Br.J Haematol. 2001; 115: 998-1001. Duba m.
  137. Iwamoto, J., Takeda, T., da Ichimura, S. Sakamakon menatetrenone akan ƙananan ma'adinai na kashin da kuma haifar da raunin kashin baya a cikin matan postmenopausal da osteoporosis: kwatankwacin tasirin etidronate. Tsakar Gida. 2001; 6: 487-492. Duba m.
  138. Sato, Y., Kaji, M., Tsuru, T., Satoh, K., da Kondo, I. Rashin bitamin K da osteopenia a cikin mata tsofaffi masu raunin bitamin D da ke fama da cutar Parkinson. Arch.Phys.Med.Ranƙarewa. 2002; 83: 86-91. Duba m.
  139. Watson, H. G., Baglin, T., Laidlaw, S. L., Makris, M., da Preston, F. E. A kwatanta inganci da ƙimar amsawa ga Vitamin K na jiji da jijiyoyin jini a cikin juyawar yawan zafin jini tare da warfarin. Br.J Haematol. 2001; 115: 145-149. Duba m.
  140. Kumar, D., Greer, F. R., Super, D. M., Suttie, J. W., da Moore, J. J. Vitamin K matsayin yara da ba a haifa ba: abubuwan da ke cikin shawarwarin yanzu. Ilimin yara 2001; 108: 1117-1122. Duba m.
  141. Nishiguchi, S., Shimoi, S., Kurooka, H., Tamori, A., Habu, D., Takeda, T., da Kubo, S. Gwajin gwajin gwaji na bitamin K2 don asarar kashi a cikin marasa lafiya tare da firam na farko cirrhosis . J.Hepatol. 2001; 35: 543-545. Duba m.
  142. Wilson, DC, Rashid, M., Durie, PR, Tsang, A., Kalnins, D., Andrew, M., Corey, M., Shin, J., Tullis, E., da Pencharz, PB Jiyya na bitamin Karancin K a cikin cystic fibrosis: Amfani da haɗin bitamin mai narkewa mai narkewa. J.Pediatr. 2001; 138: 851-855. Duba m.
  143. Pendry, K., Bhavnani, M., da Shwe, K. Yin amfani da bitamin K don magance sake-warfarinization. Br.J Haematol. 2001; 113: 839-840. Duba m.
  144. Fondevila, C.G, Grosso, S. H., Santarelli, M. T., da Pinto, M. D. Kashewar yawan zafin maganin da ya wuce kima tare da raunin maganin bitamin K1 idan aka kwatanta da katsewar acenocoumarine. Mai yiwuwa, bazuwar, buɗe karatu. Jigilar jini. Fibrinolysis 2001; 12: 9-16. Duba m.
  145. Cartmill, M., Dolan, G., Byrne, J. L., da Byrne, P. O. Prothrombin hadaddun ƙwaƙƙwa don maganin cutar ta hanyar magance cutar cikin gaggawa. Br.J Neurosurg. 2000; 14: 458-461. Duba m.
  146. Iwamoto, J., Takeda, T., da Ichimura, S. Sakamakon hada hadaddiyar gudanarwar bitamin D3 da bitamin K2 akan yawan ma'adinan kashi na kashin baya na lumbar a cikin matan da suka wuce maza da mata da osteoporosis. Tsakar Gida. 2000; 5: 546-551. Duba m.
  147. Crowther, MA, Julian, J., McCarty, D., Douketis, J., Kovacs, M., Biagoni, L., Schnurr, T., McGinnis, J., Gent, M., Hirsh, J., da kuma Ginsberg, J. Maganin coagulopathy mai hade da warfarin tare da maganin bitamin K: gwajin gwajin da bazuzu. Lancet 11-4-2000; 356: 1551-1553. Duba m.
  148. Puckett, R. M. da Offringa, M. Prophylactic bitamin K don rashin raunin bitamin K a cikin yara masu zuwa. Cochrane.Database.Syst.Rev. 2000;: CD002776. Duba m.
  149. Patel, R.J, Witt, D. M., Saseen, J. J., Tillman, D.J, da Wilkinson, D. S. Randomized, gwajin gwaji na wuribo na maganin phytonadione na maganganu don wuce gona da iri. Magunguna 2000; 20: 1159-1166. Duba m.
  150. Hung, A., Singh, S., da Tait, R.C Nazarin da ba shi da kyau don ƙayyade mafi kyawun kwayar bitamin K a cikin juyawa na over-warfarinization. Br.J Haematol. 2000; 109: 537-539. Duba m.
  151. Hylek, E. M., Chang, Y. C., Skates, S. J., Hughes, R. A., da Singer, D. E. Nazarin binciken sakamako na marasa lafiya marasa lafiya tare da yawan maganin warfarin. Arch.Intern.Med. 6-12-2000; 160: 1612-1617. Duba m.
  152. Brophy, M. T., Fiore, L. D., da Deykin, D. -ananan ƙwayoyin cutar Vitamin K a cikin Antananan Magunguna Masu Sauraro: Nazarin Neman Kashi. J.Thromb. Tsarin jini. 1997; 4: 289-292. Duba m.
  153. Raj, G., Kumar, R., da McKinney, W. P. Lokaci na juyawa daga maganin warfarin ta hanyar jijiyoyin jiki da subcutaneous phytonadione. Arch.Intern.Med. 12-13-1999; 159: 2721-2724. Duba m.
  154. Byrd, D. C., Stephens, M. A., Hamann, G. L., da Dorko, C. Subcutaneous phytonadione don juyawa daga hawan warfarin da ya haifar da Norasashen masashen Duniya. Am.J Lafiya ta Syst.Pharm. 11-15-1999; 56: 2312-2315. Duba m.
  155. Boulis, N. M., Bobek, M. P., Schmaier, A., da Hoff, J. T. Amfani da mahimmin abu na IX hadadden cikin warfarin da ke da nasaba da zubar jini na intracranial. Neurosurgery 1999; 45: 1113-1118. Duba m.
  156. Rashid, M., Durie, P., Andrew, M., Kalnins, D., Shin, J., Corey, M., Tullis, E., da Pencharz, P. B. Yaduwar yawan bitamin K a cikin cystic fibrosis. AmJJlinNutr. 1999; 70: 378-382. Duba m.
  157. Booth, S. L., O'Brien-Morse, M. E., Dallal, G. E., Davidson, K. W., da Gundberg, C. M. Amsawar matsayin bitamin K zuwa cin abinci daban-daban da kuma tushen abinci mai wadataccen phylloquinone: kwatanta yara da tsofaffi. AmJJlinNutr. 1999; 70: 368-377. Duba m.
  158. Somekawa, Y., Chigughi, M., Harada, M., da Ishibashi, T. Amfani da bitamin K2 (menatetrenone) da 1,25-dihydroxyvitamin D3 a cikin rigakafin asarar ƙashi da leuprolide ta haifar. J.Clin Endocrinol. Matab 1999; 84: 2700-2704. Duba m.
  159. Sato, Y., Tsuru, T., Oizumi, K., da Kaji, M. Rashin Vitamin na K da kuma osteopenia a cikin ɓangarorin da aka cutar da ƙwayoyin bitamin D marasa lafiyar tsofaffi marasa ƙarfi. Am.J.Phys.Med.Rashin lafiya. 1999; 78: 317-322. Duba m.
  160. Nee, R., Doppenschmidt, D., Donovan, D.J, da Andrews, T. C Intravenous da subcutaneous bitamin K1 a cikin juyawa da wuce gona da iri anticoagulation. Am JJ Cardiol. 1-15-1999; 83: 286-287. Duba m.
  161. Penning-van Beest, F. J., Rosendaal, F. R., Grobbee, D. E., van, Meegen E., da Stricker, B. H. Hanya na Norasashen Norasa na inasa a cikin mayar da martani ga bitamin K1 na baka a cikin marasa lafiya masu haɓakawa tare da phenprocoumon. Br.J Haematol. 1999; 104: 241-245. Duba m.
  162. Bolton-Smith, C., McMurdo, ME, Paterson, CR, Mole, PA, Harvey, JM, Fenton, ST, Prynne, CJ, Mishra, GD, da Shearer, MJ Shekaru biyu na gwajin kwayar cutar bitamin K1 (phylloquinone ) da bitamin D3 hade da sinadarin calcium akan lafiyar kashin tsofaffin mata. J.Bone Miner.Res. 2007; 22: 509-519. Duba m.
  163. Ishida, Y. da Kawai, S. Mahimmancin ingancin maganin maye gurbin hormone, etidronate, calcitonin, alfacalcidol, da kuma bitamin K a cikin matan postmenopausal da osteoporosis: Yamaguchi Osteoporosis Nazarin Rigakafin. Am.J.Med. 10-15-2004; 117: 549-555. Duba m.
  164. Booth SL, Golly I, Sacheck JM, et al. Amfanin karin bitamin E akan yanayin bitamin K a cikin manya tare da yanayin coagulation na al'ada. Am J Clin Nutr. 2004; 80: 143-8. Duba m.
  165. Wostmann BS, Knight PL. Antagonism tsakanin bitamin A da K a cikin ƙwayar bera. J Nutr. 1965; 87: 155-60. Duba m.
  166. Kim JS, Nafziger AN, Gaedigk A, et al. Hanyoyin bitamin K akan S- da R-warfarin pharmacokinetics da pharmacodynamics: ingantaccen amincin warfarin azaman binciken CYP2C9. J Clin Pharmacol. 2001 Jul; 41: 715-22. Duba m.
  167. Abincin bitamin K mai shiryarwa: ingantaccen dabarun don daidaita yanayin hana maganin hana yaduwar baki? Nutr Rev. 2010; 68: 178-81. Duba m.
  168. Crowther MA, Ageno W, Garcia D, et al. Oral bitamin K tare da placebo don magance yawan ƙwayar cuta a cikin marasa lafiya da ke karɓar warfarin: gwajin bazuwar. Ann Intern Med. 2009; 150: 293-300. Duba m.
  169. Jagannath VA, Fedorowicz Z, Thaker V, Chang AB. Arin Vitamin K don cystic fibrosis. Cochrane Database Syst Rev. 2011;: CD008482. Duba m.
  170. Miesner AR, Sullivan TS. Ratioaukaka daidaitattun ƙasashe daga dakatarwar ƙarin bitamin K. Ann Pharmacother 2011; 45: e2. Duba m.
  171. Ansell J, Hirsh J, Hylek E, et al. Ilimin kimiyyar magani da kuma kula da masu adawa da bitamin K: Kwalejin Kwalejin ofwararrun stwararrun stwararrun Ewararrun Sharuɗɗa na Clinical (8th Edition). Kirji 2008; 133: 160S-98S. Duba m.
  172. Rombouts EK, Rosendaal FR. Van Der Meer FJ. Vitaminarin bitamin K na yau da kullun yana inganta kwanciyar hankali. J Thromb Haemost 2007; 5: 2043-8. Duba m.
  173. Reese AM, Farnett LE, Lyons RM, et al. Vitaminananan bitamin K don ƙara yawan maganin antioagulation. Magunguna na 2005; 25: 1746-51. Duba m.
  174. Sconce E, Avery P, Wynne H, Kamali F. Vitaminarin Vitamin K na iya inganta zaman lafiyar maganin rigakafi ga marasa lafiya tare da bambancin da ba a bayyana ba game da warfarin. Jini 2007; 109: 2419-23. Duba m.
  175. Kurnik D, Lobestein R, Rabinovitz H, et al. Vitaminarin bitamin K1 mai ɗauke da ƙwayoyi masu yawa na fat-warrarin maganin ƙwayar cuta a cikin ƙwayoyin bitamin K1 masu ƙarancin ƙarfi. Thromb Haemost 2004; 92: 1018-24. Duba m.
  176. Sconce E, Khan T, Mason J, et al. Marasa lafiya tare da rashin kwanciyar hankali suna da rashin cin abincin bitamin K idan aka kwatanta da marasa lafiya tare da kulawar hana yaduwar cutar. Thromb Haemost 2005; 93: 872-5. Duba m.
  177. Tamura T, Morgan SL, Takimoto H. Vitamin K da rigakafin karaya (wasika da amsa). Arch Int Med 2007; 167: 94-5. Duba m.
  178. Beulens JW, Bots ML, Atsma F, et al. Amfani da abinci mai kyau na menaquinone yana da alaƙa da rage ƙididdigar jijiyoyin jini. Atherosclerosis 2009; 203: 489-93. Duba m.
  179. Booth SL, Dallal G, Shea MK, et al. Tasirin karin bitamin K akan rashi kashi cikin tsofaffi maza da mata. J Jarin Endocrinol Metab 2008; 93: 1217-23. Duba m.
  180. Schurgers LJ, Dissel PE, Spronk HM, et al. Matsayin bitamin K da sunadarai masu dogara da bitamin K a cikin ƙididdigar jijiyoyin jini. Z Kardiol 2001; 90 (samar da 3): 57-63. Duba m.
  181. Geleijnse JM, Vermeer C, Grobbee DE, et al. Amfani da abinci na menaquinone yana da alaƙa da rage haɗarin cututtukan zuciya: Nazarin Rotterdam. J Nutr 2004; 134: 3100-5. Duba m.
  182. Al-Terkait F, Charalambous H. Mai tsananin coagulopathy na biyu ga rashi bitamin K a cikin haƙuri tare da ƙaramin jijiyoyin ciki da kansar dubura. Lancet Oncol 2006; 7: 188. Duba m.
  183. Yoshikawa H, Yamazaki S, Watanabe T, Abe T. Rashin Vitamin na yara ƙanana masu rauni. J Yara Neurol 2003; 18: 93-7. Duba m.
  184. Schoon EJ, Muller MC, Vermeer C, et al. Serananan magani da ƙashi na bitamin K a cikin marasa lafiya tare da dogon lokaci na cutar Crohn: wani mawuyacin ƙwayoyin cuta na osteoporosis a cikin cutar Crohn? Gut 2001; 48: 473-7. Duba m.
  185. Szulc P, Meunier PJ. Shin rashi bitamin K shine haɗarin haɗari ga osteoporosis a cikin cutar Crohn? Lancet 2001; 357: 1995-6. Duba m.
  186. Duggan P, O'Brien M, Kiely M, et al. Matsayin Vitamin K a cikin marasa lafiya tare da cutar Crohn da alaƙar da juya ƙashi. Am J Gastroenterol 2004; 99: 2178-85. Duba m.
  187. Cockayne S, Adamson J, Lanham-Sabuwar S, et al. Vitamin K da rigakafin karaya. nazari na yau da kullun da kuma zane-zane na gwajin gwajin da bazuwar. Arch Intern Med 2006; 166: 1256-61. Duba m.
  188. Rejnmark L, Vestergaard P, Charles P, et al. Babu tasirin shan bitamin K akan ƙimar ma'adinai da haɗarin karaya a cikin mata masu lalata. Osteoporos Int 2006; 17: 1122-32. Duba m.
  189. Robert D, Jorgetti V, Leclercq M, et al. Shin yawan bitamin K yana haifar da lissafin mahaifa a cikin marasa lafiyar hemodialysis? Clin Nephrol 1985; 24: 300-4. Duba m.
  190. Tam DA Jr, Myer EC. Vitamin K mai dogara da coagulopathy a cikin yaron da ke karɓar maganin ƙwanƙwasa. J Yara Neurol 1996; 11: 244-6. Duba m.
  191. Keith DA, Gundberg CM, Japour A, et al. Vitamin sunadarai masu dogaro da Vitamin K da kuma maganin maye gurbi. Clin Pharmacol Ther 1983; 34: 529-32. Duba m.
  192. Thorp JA, Gaston L, Caspers DR, Pal ML. Abubuwan yau da kullun da rikice-rikice game da amfani da bitamin K. Magunguna 1995; 49: 376-87. Duba m.
  193. Bleyer WA, Skinner AL. Zubar da jini na jaririn da ke cikin jini bayan maganin hana haihuwa na mahaifiya. JAMA 1976; 235: 626-7.
  194. Renzulli P, Tuchschmid P, Eich G, et al. Farkon raunin bitamin K da zub da jini bayan cin abincin phenobarbital na uwaye: gudanarwa na zubar da jini ta cikin jiki ta hanyar karamin aiki. Eur J Pediatr 1998; 157: 663-5. Duba m.
  195. Cornelissen M, Steegers-Theunissen R, Kollee L, et al. Ofarin bitamin K a cikin mata masu ciki waɗanda ke karɓar maganin ƙarancin ƙwayar cuta yana hana rashi bitamin K na jarirai. Am J Obstet Gynecol 1993; 168: 884-8. Duba m.
  196. Cornelissen M, Steegers-Theunissen R, Kollee L, et al. Ara yawan rashi na ƙarancin bitamin K wanda ke haifar da maganin hana haihuwa na mahaifa. Am J Obstet Gynecol 1993; 168: 923-8. Duba m.
  197. MacWalter RS, Fraser HW, Armstrong KM. Orlistat yana haɓaka tasirin warfarin. Ann Pharmacother 2003; 37: 510-2. Duba m.
  198. Vroonhof K, van Rijn HJ, van Hattum J. Rashin bitamin K da zub da jini bayan an daɗe ana amfani da cholestyramine. Neth J Med 2003; 61: 19-21. Duba m.
  199. Van Steenbergen W, Vermylen J. Reversible hypoprothrombinemia a cikin mai haƙuri tare da firam biliary cirrhosis da aka kula da rifampicin. Am J Gastroenterol 1995; 90: 1526-8. Duba m.
  200. Kobayashi K, Haruta T, Maeda H, et al. Zubar da jini na kwakwalwa da ke haɗuwa da rashi bitamin K a cikin tarin tarin fuka da aka haifa tare da isoniazid da rifampin. Ciwon Pediatr Infect Dis J 2002; 21: 1088-90. Duba m.
  201. Sattler FR, Weitekamp MR, Ballard JO. Mai yuwuwar zub da jini tare da sabon maganin rigakafin beta-lactam. Ann Intern Med 1986; 105: 924-31. Duba m.
  202. Bhat RV, Deshmukh CT. Nazarin matsayin Vitamin K a cikin yara kan maganin rigakafi mai tsafta. Indiyawan Indiya 2003; 40: 36-40. Duba m.
  203. Hooper CA, Haney BB, Dutse HH. Zubar da jini na cikin hanji saboda rashi bitamin K a cikin marasa lafiya a kan cefamandole na iyaye. Lancet 1980; 1: 39-40. Duba m.
  204. Haubenstock A, Schmidt P, Zazgornik J, Balcke P, Kopsa H. Hypoprothrombobinaemic zub da jini hade da ceftriaxone. Lancet 1983; 1: 1215-6. Duba m.
  205. Dowd P, Zheng ZB. A kan tsarin aikin hana yaduwar kwayar bitamin E quinone. Kamfanin Natl Acad Sci U S A 1995; 92: 8171-5. Duba m.
  206. Bolton-Smith C, Farashin RJ, Fenton ST, et al. Ofididdigar bayanan UKasar Ingila na ɗan lokaci don maganin phylloquinone (bitamin K1) na abinci. Br J Nutr 2000; 83: 389-99. Duba m.
  207. Davies VA, Rothberg AD, Argent AC, Atkinson PM, Staub H, Pienaar NL. Matsayin prothrombin na precursor a cikin marasa lafiyar da ke karɓar kwayoyi masu rikitarwa. Lancet 1985; 1: 126-8. Duba m.
  208. Davidson MH, Hauptman J, DiGirolamo M, et al. Kula da nauyi da ragin haɗarin abubuwa a cikin batutuwa masu kiba da aka kula dasu tsawon shekaru 2 tare da jerin gwano. JAMA 1999; 281: 235-42. Duba m.
  209. Schade RWB, van't Laar A, Majoor CLH, Jansen AP. Nazarin kamantawa game da tasirin cholestyramine da neomycin a cikin maganin nau'in II hyperlipoproteinemia. Dokar Meda Scand 1976; 199: 175-80 .. Duba m.
  210. Bendich A, Langseth L. Tsaro na bitamin A. Am J Clin Nutr 1989; 49: 358-71 .. Duba m.
  211. McDuffie JR, Calis KA, Booth SL, et al. Hanyoyin yin rajista a cikin bitamin mai narkewa a cikin matasa masu kiba. Pharmacotherapy 2002; 22: 814-22 .. Duba m.
  212. Goldin BR, Lichtenstein AH, Gorbach SL. Abincin abinci da na rayuwa na ciyawar fure. A cikin: Shils ME, Olson JA, Shike M, eds. Nutrition na Zamani cikin Kiwan Lafiya da Cututtuka, 8th ed. Malvern, PA: Lea & Febiger, 1994.
  213. Hukumar Abinci da Abinci, Cibiyar Magunguna. Abinda Aka Nuna Abinci Don Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, da Zinc. Washington, DC: National Academy Press, 2002. Akwai a: www.nap.edu/books/0309072794/html/.
  214. Jamal SA, Browner WS, Bauer DC, Cummings SR. Amfani da Warfarin da haɗarin ciwon sanyin kashi a cikin mata tsofaffi. Nazarin Researchungiyar Bincike na steunƙasar Osteoporotic. Ann Intern Med 1998; 128: 829-832. Duba m.
  215. Mai Shearer MJ. Matsayi na bitamin D da K cikin lafiyar ƙashi da rigakafin osteoporosis. Sanarwar Nutr Sci 1997; 56: 915-37. Duba m.
  216. Tamatani M, Morimoto S, Nakajima M, et al. Rage matakan zagayawa na bitamin K da 25-hydroxyvitamin D a cikin tsofaffi maza osteopenic. Tsarin 1998; 47: 195-9. Duba m.
  217. Weber P. Gudanar da osteoporosis: shin akwai rawar ga bitamin K? Int J Vitam Nutr Sakamakon 1997; 67: 350-356. Duba m.
  218. Farashin PA. Vitamin K abinci da postmenopausal osteoporosis. J Jarin Kasuwanci 1993; 91: 1268. Duba m.
  219. Yonemura K, Kimura M, Miyaji T, Hishida A.Yanayin ɗan gajeren lokacin na gudanar da bitamin K a kan ɓarnatar da ƙaddarar da ke cikin prednisolone na ƙarancin ma'adinai a cikin marasa lafiya da ke fama da cutar glomerulonephritis Cungiyar Calcif Int 2000; 66: 123-8. Duba m.
  220. Knapen MH, Hamulyak K, Vermeer C. Tasirin karin bitamin K akan yaduwar osteocalcin (furotin Gla kashi) da fitsarin allurar fitsari. Ann Intern Med 1989; 111: 1001-5. Duba m.
  221. Douglas AS, Robins SP, Hutchison JD, et al. Carboxylation na osteocalcin a cikin posto-menopausal mata osteoporotic bin bitamin K da D kari. Kashi 1995; 17: 15-20. Duba m.
  222. Booth SL, Tucker KL, Chen H, et al. Abubuwan da ake amfani da shi na bitamin K suna haɗuwa da ɓarkewar ƙugu amma ba tare da ƙananan ma'adinai na ƙashi a cikin tsofaffi maza da mata ba. Am J Clin Nutr 2000; 71: 1201-8. Duba m.
  223. Heck AM, DeWitt BA, Lukes AL. Hanyoyin hulɗa tsakanin madadin hanyoyin magance warfarin. Am J Lafiya Syst Pharm 2000; 57: 1221-7. Duba m.
  224. Becker GL. Shari'ar mai ma'adinai. Am J narkewa Dis 1952; 19: 344-8. Duba m.
  225. Schwarz KB, Goldstein PD, Witztum JL, et al. Vitaminwayar bitamin mai narkewa a cikin yara hypercholestrolemic waɗanda aka kula da su tare da colestipol. Ilimin yara na yara 1980; 65: 243-50. Duba m.
  226. Knodel LC, Talbert RL. Illolin illa na magungunan hypolipidaemic. Med Toxicol 1987; 2: 10-32. Duba m.
  227. Yammacin RJ, Lloyd JK. Tasirin cholestyramine akan shafan hanji. Gut 1975; 16: 93-8. Duba m.
  228. Conly JM, Stein K, Worobetz L, Rutledge-Harding S. Taimakawar bitamin K2 (menaquinones) wanda aka samar ta microflora na hanji zuwa bukatun abinci na ɗan adam don bitamin K. Am J Gastroenterol 1994; 89: 915-23. Duba m.
  229. Hill MJ. Tsarin fure na ciki da kuma hadewar bitamin. Eur J Ciwon Cutar 1997; 6: S43-5. Duba m.
  230. Spigset O. Rage tasirin warfarin wanda sabide ubidecarenone ya haifar. Lancet 1994; 334: 1372-3. Duba m.
  231. Roche, Inc. Sanya kayan kunshin Xenical. Nutley, NJ. Mayu 1999.
  232. Feskanich D, Weber P, Willett WC, et al. Cincin Vitamin K da raunin raunin hanji a cikin mata: nazari mai zuwa. Am J Clin Nutr 1999; 69: 74-9. Duba m.
  233. Hardman JG, Limbird LL, Molinoff PB, eds. Goodman da Gillman's Tsarin Magungunan Magungunan Magunguna, 9th ed. New York, NY: McGraw-Hill, 1996.
  234. Saurayi DS. Hanyoyin Magunguna akan Gwajin Laboratory Clinical 4th ed. Washington: AACC Latsa, 1995.
  235. Corrigan JJ Jr, Marcus FI. Coagulopathy hade da cin bitamin E. JAMA 1974; 230: 1300-1. Duba m.
  236. Shearer MJ, Bach A, Kohlmeier M. Chemistry, tushen abinci mai gina jiki, rarraba nama da kuma cin abincin bitamin K tare da kulawa ta musamman game da lafiyar ƙashi. J Nutr 1996; 126: 1181S-6S. Duba m.
  237. Kanai T, Takagi T, Masuhiro K, et al. Matsarar bitamin K da ƙimar ma'adinai a cikin matan bayan-menopausal. Int J Gynaecol Obstet 1997; 56: 25-30. Duba m.
  238. Hodges SJ, Akesson K, Vergnaud P, et al. Matakan zagayawa na bitamin K1 da K2 sun ragu a cikin mata tsofaffi masu fama da karaya. J Kashin Kananan Res 1993; 8: 1241-5. Duba m.
  239. Hart JP, Shearer MJ, Klenerman L, da sauransu. Gano ilimin lantarki na matakan yaduwar bitamin K1 a cikin osteoporosis. J Jarin Endocrinol Metab 1985; 60: 1268-9. Duba m.
  240. Bitensky L, Hart JP, Catterall A, et al. Rarraba matakan bitamin K a cikin marasa lafiya tare da karaya. J Kashi na hadin gwiwa Surg Br 1988; 70: 663-4. Duba m.
  241. Nagasawa Y, Fujii M, Kajimoto Y, et al. Vitamin K2 da ƙwayar cholesterol a cikin marasa lafiya a kan ci gaba da motsa jiki. Lancet 1998; 351: 724. Duba m.
  242. Iwamoto I, Kosha S, Noguchi S, et al. Nazarin lokaci mai tsawo game da tasirin bitamin K2 akan ƙimar ma'adinan ƙashi a cikin mata postmenopausal nazarin kwatankwacin bitamin D3 da maganin estrogen-progestin. Maturitas 1999; 31: 161-4. Duba m.
  243. Vermeer C, Schurgers LJ. Binciken cikakken bitamin K da masu adawa da bitamin K. Hematol Oncol Clin Arewacin Am 2000; 14: 339-53. Duba m.
  244. Vermeer C, Gijsbers BL, Craciun AM, et al. Hanyoyin bitamin K akan ƙashin kashi da kumburin ƙashi. J Nutr 1996; 126: 1187S-91S. Duba m.
  245. Olson RE. Osteoporosis da bitamin K ci. Am J Clin Nutr 2000; 71: 1031-2. Duba m.
  246. Shiraki M, Shiraki Y, Aoki C, Miura M. Vitamin K2 (menatetrenone) yana hana ɓarkewa kuma yana riƙe da ƙwayar ma'adinin ƙashin lumbar a cikin osteoporosis. J Kashin Maɗaukaki na 2000; 15: 515-21. Duba m.
  247. Jie KG, Bots ML, Vermeer C, et al. Matsayin Vitamin K da ƙashin kashi a cikin mata tare da ba tare da ciwon atherosclerosis ba: nazarin yawan jama'a. Cungiyar Calcif Int 1996; 59: 352-6. Duba m.
  248. Caraballo PJ, Heit JA, Atkinson EJ, et al. Amfani na dogon lokaci na maganin hana yaduwar jini da kuma barazanar karaya. Arch Intern Med 1999; 159: 1750-6. Duba m.
  249. Matsunaga S, Ito H, Sakou T. Sakamakon bitamin K da D kari akan ovariectomy-jawo kashi kashi. Cungiyar Calcif Int 1999; 65: 285-9. Duba m.
  250. Ellenhorn MJ, et al. Ellenhorn's Medical Toxicology: Ganowar Cutar da Maganin Cutar Dan Adam. 2nd ed. Baltimore, MD: Williams & Wilkins, 1997.
  251. McEvoy GK, ed. AHFS Bayanin Magunguna. Bethesda, MD: Americanungiyar lafiyar Amurka-Tsarin Magunguna, 1998.
Binciken na ƙarshe - 10/26/2020

Samun Mashahuri

Menene blepharitis (kumbura ido) da yadda ake magance shi
Kiwon Lafiya

Menene blepharitis (kumbura ido) da yadda ake magance shi

Blephariti cuta ce ta kumburi a gefan gefen idanu wanda ke haifar da bayyanar pellet , cab da auran alamomi kamar u ja, ƙaiƙayi da kuma jin ɗaci a cikin ido.Wannan canjin na kowa ne kuma yana iya bayy...
Prostate cancer: mene ne, alamomin, sanadinsa da magani
Kiwon Lafiya

Prostate cancer: mene ne, alamomin, sanadinsa da magani

Cutar ankarar juzu'i cuta ce da ake yawan amu a cikin maza, mu amman ma bayan hekara 50.Gabaɗaya, wannan ciwon daji yana girma annu a hankali kuma mafi yawan lokuta baya amar da alamu a matakin fa...